Along with fully counteracted severe muscle disturbances, there were brain, heart, lung, liver, kidney and gastrointestinal tract lesions, along with progressing venous and arterial thrombosis progressing stasis, both peripherally and centrally, all of which were counteracted by BPC 157 therapy application
This is fully in-clinic training, designed to build both confidence and technical competence through supervised practice
Know the science
Clinical evidence for topical application includes studies using 50-100 mg/mL solutions with 5-aminolevulinic acid applied daily for 6 months
BPC-157 is a stable gastric pentadecapeptide originally derived from human gastric juice, TB-500 is a synthetic p
Regular use can help reduce sagging and fine lines over time